| CIMAX | GAOZX | CIMAX / GAOZX | |
| Total Expense Ratio | 0.59 | 0.65 | 91% |
| Annual Report Gross Expense Ratio | 0.59 | 0.70 | 84% |
| Fund Existence | 25 years | 9 years | - |
| Gain YTD | 8.636 | 5.223 | 165% |
| Front Load | 4% | N/A | - |
| Min. Initial Investment | 250 | 15000000 | 0% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 150B | 2.18B | 6,871% |
| Annual Yield % from dividends | 3.36 | 2.60 | 129% |
| Returns for 1 year | 4.95 | 0.35 | 1,409% |
| Returns for 3 years | 38.46 | 31.78 | 121% |
| Returns for 5 years | 27.94 | 5.70 | 490% |
| Returns for 10 years | 82.16 | N/A | - |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| SNAV | 38.72 | 0.31 | +0.81% |
| Mohr Sector Nav ETF | |||
| FGDL | 57.87 | 0.31 | +0.54% |
| Franklin Responsibly Sourced Gold ETF | |||
| TMYY | 22.38 | 0.09 | +0.38% |
| GraniteShares YieldBOOST TSM ETF | |||
| IBDW | 20.28 | -0.01 | -0.07% |
| iShares iBonds Dec 2031 Term Corp ETF | |||
| LFSC | 45.33 | -0.04 | -0.10% |
| F/m Emerald Life Sciences Innovation ETF | |||